3//SEC Filing
SOFINNOVA VENTURE PARTNERS V LP 3
Accession 0001181431-05-007010
CIK 0001183765other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:19 PM ET
Size
23.7 KB
Accession
0001181431-05-007010
Insider Transaction Report
Form 3
HEALY JAMES
10% Owner
Holdings
- (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying) - (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying)
Sofinnova Management V LLC
10% Owner
Holdings
- (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying) - (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying)
SOFINNOVA VENTURE AFFILIATES V LP
10% Owner
Holdings
- (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying) - (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying)
POWELL MICHAEL
Director10% Owner
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying) - (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying)
SOFINNOVA VENTURE PARTNERS V LP
10% Owner
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying) - (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying)
Azan Alain
10% Owner
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying) - (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying)
SOFINNOVA VENTURE PRINCIPALS V LP
10% Owner
Holdings
- (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (1,755,337 underlying) - (indirect: See Footnote)
Series A Preferred Stock
→ Common Stock (1,303,337 underlying)
Footnotes (7)
- [F1]Immediately.
- [F2]Not Applicable.
- [F3]Reflects a 1 for 1.6469 reverse stock split effective as of January 26, 2005.
- [F4]Each share is convertible without consideration into 0.6072 shares of Common Stock, after giving effect to a 1 for 1.6469 reverse stock split effective as of January 26, 2005.
- [F5]Shares owned directly by Sofinnova Venture Partners V, L.P. (SVP). Reporting person, a director of Threshold Pharmaceuticals, Inc., is a managing member of Sofinnova Management V, L.L.C. (SM), which is the general partner of SVP. Reporting person disclaims beneficial ownership in the shares held by SVP except to the extent of any indirect pecuniary interest therein. James Healy and Alain Azan are both managing members of SM and each disclaims beneficial ownership in the shares held by SVP except to the extent of any indirect pecuniary interest.
- [F6]Shares owned directly by Sofinnova Venture Affiliates V, L.P. (SVA). Reporting person, a director of Threshold Pharmaceuticals, Inc., is a managing member of SM, which is the general partner of SVA. Reporting person disclaims beneficial ownership in the shares held by SVA except to the extent of any indirect pecuniary interest therein. James Healy and Alain Azan are both managing members of SM and each disclaims beneficial ownership in the shares held by SVA except to the extent of any indirect pecuniary interest.
- [F7]Shares owned directly by Sofinnova Venture Principals V, L.P. (SVP 11). Reporting person, a director of Threshold Pharmaceuticals, Inc., is a managing member of SM, which is the general partner of SVP 11. Reporting person disclaims beneficial ownership in the shares held by SVP 11 except to the extent of any indirect pecuniary interest therein. James Healy and Alain Azan are both managing members of SM and each disclaims beneficial ownership in the shares held by SVP 11 except to the extent of any indirect pecuniary interest.
Issuer
THRESHOLD PHARMACEUTICALS INC
CIK 0001183765
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001108554
Filing Metadata
- Form type
- 3
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:19 PM ET
- Size
- 23.7 KB